PCI Pharma Services (PCI), a pharma and biopharma global supply chain solutions provider, acquired Bellwyck Pharma Services, headquartered in Toronto, Canada. Bellwyck is a provider of primary and secondary packaging and labeling for clinical trial and commercial drug markets. The acquisition will add four GMP-compliant facilities to the PCI network in the U.S., Germany and Canada. PCI is headquartered in Philadelphia, PA. Bellwyck’s clinical and commercial supply chain solutions complement ...